Update on the COVID-19 pandemic

Information regarding COVID-19 is in constant change, as is the situation regarding vaccination and prioritization for immune-compromised individuals.

If you have any COVID-19-related questions, we’ve created a specific COVID section on our website that can be accessed by clicking here or by selecting the “News & Events” tab from our homepage. In this section, you’ll find the latest news and information about the pandemic in Canada from trustworthy and reliable sources.

Any specific questions that you may have regarding the COVID-19 vaccination, delays between vaccine dosing, and prioritization within your province are best answered by your healthcare team. They’re the ones who know you and your particular situation and are therefore in a position to best address your unique concerns.

Created by, and entirely focused on, Canadians impacted by myeloma, Myeloma Canada is the only national charitable organization committed to providing you with the most up-to-date and reliable information on myeloma. Some of the ways we do this is through our monthly e-newsletter, “Myeloma Matters”, as well as through our social media platforms.

Please don’t hesitate to contact us at contact@myeloma.ca or toll-free at 1-888-798-5771 with any questions regarding our programs and services.

Close

Make a donation

Know Your Rights

As a research participant, you have the right to be treated fairly, respectfully, and be free from pressure and interference when making decisions. If you are requesting information about a study, you also have the right to be told about:

  • All of your options and whether they might be better or worse than being in the study
  • What the trial is trying to find out
  • The possible risks, side effects and benefits of the study
  • What drugs, procedures or devices are different from what is used in standard care
  • What treatments are available if any medical problems arise
  • If the information learned during the study might affect your safety

Lastly, all of the personal information collected during a clinical trial is confidential and will be protected, even after you have completed or left the study.